Demand Forecast
Drill-down by category, sub-category, or SKU (p50 + p95 model)
SKU · ABE35301101261013442
PACK = Biotine Plus 450,000 mcg 90 comprimés + Gratuite Zinc 30 Comprimés + VITAMINE C 30 Comprimés
longtail
3P
MEDICAMENTS
Last 4 weeks demand
3
▲ 50.0% vs prev 4w
Offer Stock
94
Σ Stock across 1 live offer (1P + 3P) · 2026-11-03
1P stock
0
no 1P (MARJANEMALL) stock in the 2026-11-03 snapshot
Unit price
MAD 170
avg of last 4 sells · latest 2026-10-25
ABE35301101261013442
History (last 52 weeks) and LightGBM p95-quantile forecast for the SKU.
Cutoff: 2026-11-02 · Total forecast: 29 units.
Actual
Realistic forecast (p50)
Optimistic
Out of stock
Price history
Weekly qty-weighted average (MAD) of every non-null price/cost column in the OrderBook for this SKU. Click a legend entry to hide/show a line.
Why this forecast?
PACK = Biotine Plus 450,000 mcg 90 comprimés + Gratuite Zinc 30 Comprimés + VITAMINE C 30 Comprimés · in the longtail cohort · last 4 weeks 3 units, trending up +50.0% · on-hand 94 units
Signals the model saw
- Cohort: longtail (224 days of history, — units sold over 52 weeks)
- Volatility (CV): 0.37 — low
- Recent trend: last 4w = 3 units · prev 4w = 2 units
- Stockouts (last 13 weeks): none — history is reliable
- Calendar events firing in forecast window: none
Model output
| Realistic forecast — next week | 0.0 units |
| Realistic forecast — next 4 weeks | 0.0 units |
| Realistic forecast — next 3 months | 0.1 units |
| Planning level (p75) — next 4 weeks the order-sizing basis; demand exceeds it ~1 week in 4 | 0.0 units |
| Optimistic — next week | 1.9 units |
| Optimistic — next 4 weeks (reorder target) | 8.5 units |
| Optimistic — next 3 months (quarterly PO target) | 29.4 units |
| Legacy μ/wk (reorder pipeline) | — |
| Revenue exposure — optimistic, 3 months | MAD 5.0K |